|
Atai Life Sciences N.V. (ATAI) DCF Valuation |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
Atai Life Sciences N.V. (ATAI) Bundle
Discover the true value of Atai Life Sciences N.V. (ATAI) with our advanced DCF Calculator! Adjust key assumptions, explore various scenarios, and assess how changes influence Atai Life Sciences N.V. (ATAI) valuation – all within a single Excel template.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | 20.4 | .2 | .3 | .3 | .3 | .2 | .2 | .1 | .1 |
| Revenue Growth, % | 0 | 0 | -98.86 | 34.76 | -1.91 | -16.5 | -16.5 | -16.5 | -16.5 | -16.5 |
| EBITDA | -92.1 | -120.3 | -135.0 | -36.3 | -145.3 | -.2 | -.1 | -.1 | -.1 | -.1 |
| EBITDA, % | 100 | -590.29 | -57945.92 | -11564.01 | -47186.04 | -60 | -60 | -60 | -60 | -60 |
| Depreciation | .0 | .0 | .2 | .3 | .5 | .2 | .2 | .1 | .1 | .1 |
| Depreciation, % | 100 | 0.23066 | 72.1 | 101.59 | 153.57 | 74.47 | 74.47 | 74.47 | 74.47 | 74.47 |
| EBIT | -92.1 | -120.3 | -135.2 | -36.6 | -145.8 | -.2 | -.1 | -.1 | -.1 | -.1 |
| EBIT, % | 100 | -590.52 | -58018.03 | -11665.61 | -47339.61 | -60 | -60 | -60 | -60 | -60 |
| Total Cash | 97.2 | 362.3 | 273.1 | 179.3 | 62.3 | .3 | .2 | .2 | .1 | .1 |
| Total Cash, percent | .0 | .0 | .1 | .1 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 1.3 | 6.3 | 5.6 | 2.3 | 1.3 | .2 | .2 | .2 | .1 | .1 |
| Account Receivables, % | 100 | 31.01 | 2416.74 | 718.79 | 437.66 | 86.2 | 86.2 | 86.2 | 86.2 | 86.2 |
| Inventories | .5 | .0 | -5.6 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 100 | 0 | -2416.74 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payable | 3.1 | 6.0 | 2.4 | 4.6 | 2.6 | .2 | .2 | .2 | .1 | .1 |
| Accounts Payable, % | 100 | 29.47 | 1029.61 | 1461.46 | 849.35 | 85.89 | 85.89 | 85.89 | 85.89 | 85.89 |
| Capital Expenditure | -.1 | -1.1 | -1.0 | -.6 | -.1 | -.1 | -.1 | -.1 | -.1 | -.1 |
| Capital Expenditure, % | 100 | -5.54 | -439.48 | -187.9 | -30.84 | -47.28 | -47.28 | -47.28 | -47.28 | -47.28 |
| Tax Rate, % | -0.58219 | -0.58219 | -0.58219 | -0.58219 | -0.58219 | -0.58219 | -0.58219 | -0.58219 | -0.58219 | -0.58219 |
| EBITAT | -92.4 | -116.8 | -141.4 | -37.5 | -146.7 | -.2 | -.1 | -.1 | -.1 | -.1 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -91.1 | -119.5 | -139.6 | -37.8 | -147.3 | -1.4 | -.1 | -.1 | .0 | .0 |
| WACC, % | 10.87 | 10.85 | 10.87 | 10.87 | 10.87 | 10.86 | 10.86 | 10.86 | 10.86 | 10.86 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -1.4 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | -2 | |||||||||
| Net Debt | 7 | |||||||||
| Equity Value | -9 | |||||||||
| Diluted Shares Outstanding, MM | 160 | |||||||||
| Equity Value Per Share | -0.06 |
What You Will Get
- Real Atai Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for Atai Life Sciences N.V. (ATAI).
- Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates specific to Atai Life Sciences N.V. (ATAI).
- Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on Atai Life Sciences N.V. (ATAI) fair value.
- Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections for Atai Life Sciences N.V. (ATAI).
- Time-Saving and Accurate: Skip building models from scratch while maintaining precision and flexibility for Atai Life Sciences N.V. (ATAI).
Key Features
- Comprehensive DCF Model: Offers in-depth unlevered and levered DCF valuation frameworks.
- WACC Analysis Tool: Ready-to-use Weighted Average Cost of Capital calculator with adjustable parameters.
- Customizable Forecast Inputs: Tailor growth projections, capital investments, and discount rates as needed.
- Integrated Financial Metrics: Evaluate profitability, leverage, and efficiency ratios specific to Atai Life Sciences N.V. (ATAI).
- Interactive Dashboard and Visuals: Graphical representations highlight essential valuation indicators for straightforward assessment.
How It Works
- Download the Template: Gain immediate access to the Excel-based ATAI DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and additional parameters.
- Instant Calculations: The model automatically recalculates Atai Life Sciences' intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
- Analyze and Decide: Utilize the outcomes to inform your investment or financial analysis decisions.
Why Choose This Calculator for Atai Life Sciences N.V. (ATAI)?
- Designed for Experts: A sophisticated tool utilized by researchers, investment analysts, and healthcare professionals.
- Comprehensive Data: Atai’s historical and projected financials included for precise analysis.
- Flexible Scenario Analysis: Easily simulate various forecasts and assumptions.
- Insightful Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
- User-Friendly: Step-by-step guidance ensures a smooth calculation process.
Who Should Use This Product?
- Individual Investors: Gain insights to make informed decisions regarding investments in Atai Life Sciences N.V. (ATAI).
- Financial Analysts: Enhance valuation methodologies with readily available financial models tailored for Atai Life Sciences N.V. (ATAI).
- Consultants: Provide clients with accurate and timely valuation assessments of Atai Life Sciences N.V. (ATAI).
- Business Owners: Learn about the valuation of biotech companies like Atai Life Sciences N.V. (ATAI) to inform your own business strategy.
- Finance Students: Explore real-world valuation techniques using data from Atai Life Sciences N.V. (ATAI) to enhance learning.
What the Template Contains
- Preloaded ATAI Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
- Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
- Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.